Table 2. Univariate and Multivariate Analyses for 3-Year Post-Recurrence Survival.
Variables | Univariate Analysis | Multivariate Analysis | ||
---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
Age at diagnosis, years | ||||
< 50* | ||||
≥ 50 | 1.57 (0.80–3.06) | 0.187 | ||
Sex | ||||
Male* | ||||
Female | 0.54 (0.27–1.09) | 0.086 | ||
Type of gastrectomy | ||||
Total* | ||||
Subtotal | 0.69 (0.35–1.36) | 0.282 | ||
Pathologic T stage† | ||||
T1* | ||||
T2 | 1.35 (0.32–5.71) | 0.682 | ||
T3 | 0.86 (0.21–3.61) | 0.837 | ||
T4 | 1.77 (0.53–5.89) | 0.355 | ||
Pathologic N stage† | ||||
N0* | ||||
N1 | 0.78 (0.17–3.69) | 0.754 | ||
N2 | 2.39 (0.79–7.13) | 0.119 | ||
N3 | 2.01 (0.89–4.51) | 0.091 | ||
TNM stage† | ||||
I* | ||||
II | 0.95 (0.26–3.53) | 0.942 | ||
III | 1.79 (0.54–5.97) | 0.337 | ||
Histopathologic subtype | ||||
Adenocarcinoma* | ||||
Signet ring cell | 1.26 (0.65–2.43) | 0.493 | ||
Lauren histotype | ||||
Diffuse* | ||||
Intestinal | 0.68 (0.33–1.41) | 0.298 | ||
LNR | ||||
≤ 0.063* | ||||
> 0.063 | 2.22 (1.12–4.43) | 0.023 | ||
SUVmax | ||||
≤ 5.1* | ||||
> 5.1 | 3.30 (1.58–6.87) | 0.001 | 2.57 (1.16–5.69) | 0.012 |
Weight loss, % | ||||
≤ 14.7* | ||||
> 14.7 | 2.91 (1.48–5.71) | 0.002 | 2.24 (1.11–4.56) | 0.025 |
Hemoglobin, g/dL | ||||
≥ 11.4* | ||||
< 11.4 | 1.88 (0.98–3.58) | 0.055 | ||
Neutrophil count, cells/uL | ||||
≤ 2997* | ||||
> 2997 | 2.89 (1.45–5.79) | 0.003 | 2.68 (1.32–5.43) | 0.006 |
Lymphocyte count, cells/uL | ||||
≤ 1084* | ||||
> 1084 | 0.58 (0.30–1.10) | 0.095 | ||
Platelet count, cells/uL | ||||
≥ 154000* | ||||
< 154000 | 2.16 (0.88–5.31) | 0.094 | ||
Recurrence timing | ||||
Early, ≤ 2 years | 2.40 (1.18–4.91) | 0.016 | ||
Late, > 2 years* | ||||
First sites of recurrence | ||||
Locoregional recurrence only* | ||||
Distant metastasis only | 1.49 (0.52–4.31) | 0.458 | ||
Locoregional and distant failure | 2.62 (0.81–8.41) | 0.107 |
*Reference of categorical parameter, †According to 8th AJCC staging system. CI = confidence interval, HR = hazard ratio